WWA
ABBV icon

Wealth Watch Advisors’s AbbVie ABBV Stock Holding History

Wealth Watch Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
+993
New +$214K 0.08% 114
2026
Q1 		– Sell
-693
Closed -$158K – 129
2025
Q4 		$158K Sell
693
-215
-24% -$49K 0.06% 113
2025
Q3 		$210K Buy
+908
New +$185K 0.09% 88

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealth Watch Advisors's ABBV Position: Q2 2026 in Review

Wealth Watch Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 993 shares worth $250K. The stake represents 0.08% of the portfolio and ranks #114 among its holdings. This is a return to the name: Wealth Watch Advisors previously reported a position in ABBV as recently as Q4 2025.

Wealth Watch Advisors first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealth Watch Advisors held 993 shares of AbbVie worth $250K as of Q2 2026.
  • AbbVie was a new Wealth Watch Advisors position in Q2 2026.
  • AbbVie made up 0.08% of Wealth Watch Advisors's portfolio in Q2 2026, its #114 holding.
  • Wealth Watch Advisors first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Watch Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.